Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q1 EPS of ($0.59), $0.06 better than the analyst estimate of ($0.65). Revenue for the quarter came in at $0 versus the consensus estimate of $800 thousand.

For earnings history and earnings-related data on Syndax Pharmaceuticals (SNDX) click here.